Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinoma
about
CXCL9: evidence and contradictions for its role in tumor progression.CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer.Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.Prospects for combined use of oncolytic viruses and CAR T-cells.The Microenvironment in Epstein-Barr Virus-Associated Malignancies.Associations of Epstein-Barr Virus-Positive Gastric Adenocarcinoma with Circulating Mediators of Inflammation and Immune Response
P2860
Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Serum CXCL9 levels are associa ...... with nasopharyngeal carcinoma
@ast
Serum CXCL9 levels are associa ...... with nasopharyngeal carcinoma
@en
type
label
Serum CXCL9 levels are associa ...... with nasopharyngeal carcinoma
@ast
Serum CXCL9 levels are associa ...... with nasopharyngeal carcinoma
@en
prefLabel
Serum CXCL9 levels are associa ...... with nasopharyngeal carcinoma
@ast
Serum CXCL9 levels are associa ...... with nasopharyngeal carcinoma
@en
P2093
P2860
P1433
P1476
Serum CXCL9 levels are associa ...... with nasopharyngeal carcinoma
@en
P2093
Cheng-Lung Hsu
Huang-Kai Kao
I-How Chen
Kai-Ping Chang
Li-Jen Hsin
Ngan-Ming Tsang
Shiau-Chin Liu
Yu-Sun Chang
P2860
P304
P356
10.1371/JOURNAL.PONE.0080052
P407
P577
2013-11-21T00:00:00Z